Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tonix Pharmaceuticals Holding (TNXP) Return on Assets (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Return on Assets data on record, last reported at 0.45% in Q3 2025.

  • For Q3 2025, Return on Assets rose 126.0% year-over-year to 0.45%; the TTM value through Sep 2025 reached 0.45%, up 126.0%, while the annual FY2024 figure was 0.86%, N/A changed from the prior year.
  • Return on Assets reached 0.45% in Q3 2025 per TNXP's latest filing, down from 0.43% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.43% in Q2 2025 and bottomed at 1.71% in Q3 2024.
  • Average Return on Assets over 3 years is 0.93%, with a median of 0.77% recorded in 2025.
  • Peak YoY movement for Return on Assets: dropped -26bps in 2024, then skyrocketed 126bps in 2025.
  • A 3-year view of Return on Assets shows it stood at 0.8% in 2023, then plummeted by -33bps to 1.06% in 2024, then skyrocketed by 58bps to 0.45% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.45% in Q3 2025, 0.43% in Q2 2025, and 0.74% in Q1 2025.